The Nasdaq Is Down 3% This Year. Is the QQQ Invesco Trust Still Worth Buying Right Now?

Nasdaq is down ~3% YTD while the S&P 500 is down >1%; Invesco QQQ (tracks the Nasdaq-100) is roughly 60% tech and its top three holdings (Nvidia, Apple, Microsoft) account for ~22% of the fund. QQQ has returned >460% over the past decade versus ~233% for the S&P 500, but concentrated tech exposure and sensitivity to AI spending and valuation concerns increase near-term downside risk amid economic and geopolitical uncertainty. For multi-year investors the ETF can remain attractive if willing to tolerate short-term volatility, but the near-term view is cautious.

Analysis

The current weakness in growth is being amplified by concentration and positioning rather than just fundamentals: passive flows into a handful of mega-caps create a feedback loop where modest outflows force outsized liquidation of the top names, which then raises realized and implied volatility and draws short-term momentum selling. That dynamic benefits liquidity providers, exchanges, and volatility sellers/buyers asymmetrically — expect trading volumes and bid/offer friction to rise during drawdowns, lifting NDAQ P&L from fees and spreads even if index NAVs fall.

AI spending is the primary binary for 6–18 month outcomes. If enterprise AI budgets reaccelerate on the next earnings/guide season, NVDA asymmetrically captures incremental revenue and margin upside because of its middleware-like position in model training stacks; conversely, a measured pullback in AI capex would compress multiples across the largest tech names and disproportionately hurt stocks with higher forward growth premia (where AAPL/MSFT appear most vulnerable to sentiment-driven multiple contraction).

Regional/geopolitical friction around chip supply is a second-order lever: renewed export controls would widen the valuation gap between fab-lite designers (NVDA) and integrated manufacturers (INTC), but would also shorten the pathway for domestic fabs to capture incremental orders — a 6–24 month positive for capex-heavy names and for firms selling factory equipment and test services. Lastly, technicals matter: quarterly index rebalances and large option expiries are likely to produce 1–3 week microtrends; use those windows for tactical, high-conviction exposures rather than buy-and-hold entries at current sentiment levels.

Key Decisions for Investors

• Relative-value pair (3–9 months): Long NVDA / Short QQQ (equal notional). Rationale: express conviction in NVDA’s idiosyncratic AI capture while hedging broad tech multiple risk. Target: +35% net on NVDA leg with downside capped to -25% if AI spend collapses; rebalance if NVDA outperforms by >20%.
• Event-driven trade (30–90 days): Buy NDAQ ahead of volatility spikes around rebalances/expiries (20–40% notional in options or 2–3% of book in stock). Expect higher fee income and spreads to lift results; hedge with modest short on QQQ to neutralize market beta. Target 15–25% return vs limited downside if a market-wide rally removes volatility premium.
• Tactical options spread (6–12 months): Buy NVDA 9–12 month call spread (e.g., 25–35% OTM) financed by selling MSFT 9–12 month calls (10–20% OTM). Rationale: pay for asymmetric upside to AI hardware capture while monetizing MSFT’s tame vol and weaker sentiment. Risk/reward ~1:3 if NVDA rerates; max loss limited to net debit.
• Defensive hedge (days–months): If market breadth deteriorates below critical thresholds or QQQ gaps below the 50-day average, buy inexpensive protection via QQQ put calendar or VIX call spread for 2–8% of portfolio AUM. This hedges concentrated drawdowns without long-term carry drag.
• Contrarian accumulation (12–36 months): Dollar-cost into beaten-up, high-quality software/consumer franchises (selectively NFLX) on pullbacks >20% from short-term peaks, sizing initial positions small and layering on positive revenue/ARPU inflection. Expect multi-year payoff if secular cashflows reaccelerate; cap position size to 3–5% of equity allocation until evidence of sustained recovery.